To unlock the Will of Galacta cosmetics featured in this Season 1 Twitch Drop, connect your Marvel Rivals account with your Twitch account, then watch any of the streams in the Marvel Rivals ...

AbbVie (NYSE:ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic drugmaker Samsung Bioepis said in a new report on Thursday as the ...

Once Humira biosimilars entered the US markets in 2023, drug revenues declined by 32% for AbbVie. Image credit: Skorzewiak / Shutterstock AbbVie executives say the company’s immunology drugs Skyrizi ...

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for sustainable success in 2025. With explosive deals out of the way, news from ...

Gifting allows recipients to access the article for free. AbbVie leaders are “disappointed” with poor results from a schizophrenia drug the company acquired last year that led to a $3.5 ...

Jan 15 (Reuters) - AbbVie (ABBV.N), opens new tab plans to "commit less capital" towards experimental medicines for psychiatric disease, CEO Robert Michael said at an industry conference on ...

AbbVie will receive royalties on net sales within Greater China. Credit: © AbbVie Inc. All rights reserved. AbbVie and Simcere Zaiming have announced an option-to ...

Vancouver, BC, January 15, 2025--(T-Net)--AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell ...

Deputy City Administrator David Forte has resigned from the city of Pensacola. Forte resigned from the city on Jan. 6, which means the city lost two senior-level officials last week. Port Director ...

AbbVie’s ABBV stock has declined 8% in the past three months. A lot of this price decline is due to the poor performance of the overall drug and biotech sector in the past couple of months after ...